GABAB receptors in the NTS mediate the inhibitory effect of trigeminal nociceptive inputs on parasympathetic reflex vasodilation in the rat masseter muscle.
The present study was designed to examine whether trigeminal nociceptive inputs are involved in the modulation of parasympathetic reflex vasodilation in the jaw muscles. This was accomplished by investigating the effects of noxious stimulation to the orofacial area with capsaicin, and by microinjecting GABA(A) and GABA(B) receptor agonists or antagonists into the nucleus of the solitary tract (NTS), on masseter hemodynamics in urethane-anesthetized rats. Electrical stimulation of the central cut end of the cervical vagus nerve (cVN) in sympathectomized animals bilaterally increased blood flow in the masseter muscle (MBF). Increases in MBF evoked by cVN stimulation were markedly reduced following injection of capsaicin into the anterior tongue in the distribution of the lingual nerve or lower lip, but not when injected into the skin of the dorsum of the foot. Intravenous administration of either phentolamine or propranolol had no effect on the inhibitory effects of capsaicin injection on the increases of MBF evoked by cVN stimulation, which were largely abolished by microinjecting the GABA(B) receptor agonist baclofen into the NTS. Microinjection of the GABA(B) receptor antagonist CGP-35348 into the NTS markedly attenuated the capsaicin-induced inhibition of MBF increase evoked by cVN stimulation, while microinjection of the GABA(A) receptor antagonist bicuculline did not. Our results indicate that trigeminal nociceptive inputs inhibit vagal-parasympathetic reflex vasodilation in the masseter muscle and suggest that the activation of GABA(B) rather than GABA(A) receptors underlies the observed inhibition in the NTS.
Division of Physiology, Department of Oral Biology, School of Dentistry, Health Sciences University of Hokkaido, Ishikari-Tobetsu, Hokkaido, Japan.
Hisayoshi
H
Ishii
Hiroshi
H
Izumi
D018674:Adrenergic Antagonists / Q000494:pharmacology; D000818:Animals; D001418:Baclofen / Q000494:pharmacology; D002211:Capsaicin / Q000494:pharmacology; D004558:Electric Stimulation; D058785:GABA-A Receptor Agonists / Q000494:pharmacology; D008297:Male; D008406:Masseter Muscle / Q000098:blood supply*; D023421:Models, Animal; D059225:Nociception / Q000502:physiology*; D010275:Parasympathetic Nervous System / Q000502:physiology*; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D018080:Receptors, GABA-B / Q000187:drug effects / Q000502:physiology*; D012039:Regional Blood Flow / Q000502:physiology; D018689:Sensory System Agents / Q000494:pharmacology; D017552:Solitary Nucleus / Q000502:physiology*; D014276:Trigeminal Nerve / Q000502:physiology*; D014664:Vasodilation / Q000502:physiology*
D018674:Adrenergic Antagonists; D058785:GABA-A Receptor Agonists; D018080:Receptors, GABA-B; D018689:Sensory System Agents; D011433:Propranolol; D001418:Baclofen; D002211:Capsaicin; D010646:Phentolamine